Position in NTRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,173,478
+$96,532 QoQ
Shares Held
4,323
-19.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#426
of 844 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026&PARTNERS holds $76,040,383 across 16 Diagnostics & Research names. NTRA ranks #12 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DGX |
Quest Diagnostics Inc
|
124,363 | $26,358,737 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
28,690 | $14,384,018 | |
| 3 | DHR |
Danaher Corp /De/
|
58,225 | $11,090,698 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
6,313 | $3,323,415 | |
| 5 | WAT |
Waters Corp /De/
|
8,275 | $3,103,456 | |
| 6 | LH |
Labcorp Holdings Inc.
|
10,611 | $2,971,080 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
14,309 | $2,764,784 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
4,426 | $2,343,965 |
All Filings in NTRA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,173,478 | 4,323 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,076,946 | 5,385 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,049,919 | 4,583 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $557,278 | 3,462 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $375,891 | 2,225 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $415,462 | 2,938 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $353,958 | 2,236 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||